Singaporean medical technology startup and doctor Lynne Lim wins first prize at Cartier Women’s Initiative 2024

Transformative women from around the world gathered at the magnificent Shenzhen Bay Opera House on the evening of May 22. They came together to celebrate the 17th edition of the Cartier Women’s Initiative (CWI), an annual impact business program initiated by the French jewelry house.

The CWI aims to support impactful women entrepreneurs who are generating changes in society. Since its inception in 2006, it has expanded to encompass 11 categories, including nine regional awards and two thematic awards. the Science and Technology Pioneer Award was launched in 2021 and the Diversity, Equity and Inclusion Award was introduced in 2023.

A distinguished jury selects the top three applicants in each category, awarding first, second and third place and US$100,000, US$60,000 and US$30,000 in grants respectively.

Beyond the financial rewards, awardees, known as “fellows,” join a community that provides them with access to personalized mentoring and training, media visibility, networking opportunities, and educational courses from leading business school INSEAD.


This year, Singapore-based Dr Lynne Lim, an ear, nose and throat (ENT) surgeon and founder of medical technology startup NOUSQ, was one of three honorees in the Science and Technology Pioneer category. Dr Lim took home the first prize in the category. According to Cartier, this year there were a total of 234 applicants for the Pioneers in Science and Technology category.

NOUSQ created CLiKX, the world’s first wearable robotic device for ear tube surgery without the use of microscopes or general anesthesia. The device is an innovative solution for otitis media with effusion (OME), also known as “glue ear,” a condition in which fluid builds up inside the middle ear and does not go away. It is the main cause of hearing loss in children.